3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Vascular Diseases
1
Respiratory Tract Diseases
1
Pulmonary Embolism
1
Neoplasms
1
Lung Diseases
1
Embolism and Thrombosis
1
Embolism
1
Disease
1
Cardiovascular Diseases
1
Interventions
Blood Specimen Collection
5
Mammography
4
Tomography, X-Ray Computed
3
Surveys and Questionnaires
3
Colonoscopy
3
Biopsy
3
Preoperative Exercise
2
Positron Emission Tomography Computed Tomography
2
Methods
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Exercise
2
Educational Status
2
Control Groups
2
Biopsy, Fine-Needle
2
Water
1
Waiting Lists
1
Vertical Dimension
1
Urine Specimen Collection
1
Urination
1
Ultrasonography
1
Triamcinolone Acetonide
1
Transcutaneous Electric Nerve Stimulation
1
Transcatheter Aortic Valve Replacement
1
Thoracoscopy
1
Thoracic Surgical Procedures
1
Therapeutics
1
Standard of Care
1
Sensitivity Training Groups
1
Patient Positioning
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Disease
×
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled